Market Overview

According to fortune business insights, the global neurovascular devices market is witnessing significant growth, driven by the increasing prevalence of neurological disorders, rising awareness of minimally invasive treatment options, and continuous technological advancements in interventional neurology. Neurovascular devices are specialized medical instruments used to diagnose and treat conditions affecting blood vessels in the brain, including cerebral aneurysms, ischemic strokes, and other cerebrovascular disorders.

According to Fortune Business Insights™, the global neurovascular devices market size was valued at USD 4.08 billion in 2025. The market is projected to grow from USD 4.46 billion in 2026 to USD 9.82 billion by 2034, exhibiting a CAGR of 10.40% during the forecast period (2026–2034). North America dominated the market, accounting for a 43.60% share in 2025.

The rising incidence of strokes and brain aneurysms, particularly among the aging population, is increasing the demand for effective neurovascular interventions. Furthermore, growing investments in research and development and the introduction of advanced embolization and thrombectomy technologies are supporting market expansion.

Major Players Profiled

Market Segmentation

By Device Type: The market is segmented into stenting systems, embolization devices, neurothrombectomy devices, and support devices. The embolization devices segment dominated the market, accounting for 45.29% of the market share in 2026. Its leadership is supported by the growing number of cerebral aneurysm treatments and the introduction of advanced embolization technologies. Neurothrombectomy devices are also expected to experience considerable growth due to the increasing incidence of ischemic strokes and rising adoption of mechanical thrombectomy procedures.

By Application: The market is categorized into cerebral aneurysms, ischemic stroke, and others. The cerebral aneurysms segment represents a significant market share due to the increasing prevalence of aneurysms and the availability of advanced treatment technologies. Meanwhile, the ischemic stroke segment is anticipated to grow substantially as mechanical thrombectomy becomes increasingly important in managing acute ischemic stroke.

By End-user: The market is divided into hospitals, specialty clinics, and others. Hospitals are expected to dominate, accounting for 72.20% of the market share in 2026, supported by advanced medical infrastructure, higher patient admissions, and the availability of specialized neurointerventional facilities.

For detailed market insights: https://www.fortunebusinessinsights.com/industry-reports/neurovascular-devices-interventional-neurology-market-101684